• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Dyslipidemia

Dyslipidemia

9780199742868
287.75 zł
258.97 zł Save 28.78 zł Tax included
Lowest price within 30 days before promotion: 258.97 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Dyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardialinfarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control.As part of the Oxford American Cardiology Library, this practical handbook is designed to serve as a concise yet authoritative resource on diagnosing and treating dyslipidemia. The book is tailored to the needs of busy health care professionals treating patients in various clinical settings, and focuses on presenting essential information to clinicians who are at the forefront of the diagnosis and management of dyslipidemia. Featuring evidence-based, concise yet comprehensivediscussion of key clinical concepts in addition to numerous figures, tables and illustrations, this pocket-sized handbook will serve as an invaluable guide to healthcare professionals.
Product Details
OUP USA
86799
9780199742868
9780199742868

Data sheet

Publication date
2011
Issue number
1
Cover
paperback
Pages count
152
Dimensions (mm)
203 x 127
Weight (g)
187
  • Contributors; 1. LDL Cholesterol; 2. HDL Cholesterol; 3. Non-HDL Cholesterol; 4. Use of High Sensitivity C-reactive Protein for Risk Assessment; 5. Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements; 6. Stratification of Dyslipidemic Risk; 7. Drugs for Treatment of Blood Lipoprotein Abnormalities; Index;
Comments (0)